Andrew Hedin is a partner in Bessemer’s Cambridge office where he focuses on investments broadly across the healthcare ecosystem, including new biotech therapeutics as well as software and services sold to healthcare verticals.
Prior to joining Bessemer in 2015, Andrew worked at F-Prime Capital, Fidelity’s healthcare-focused venture capital fund where he invested in early-stage biotech and digital health technologies, as well as Leerink Partners as an advisor to the biopharma industry.
He earned an MBA with honors from The Wharton School, where he majored in health care management and finance, as well as a degree in biological basis of behavior from the University of Pennsylvania.
Andrew grew up in Western New York in a family that cherished their Swedish heritage and prioritized faith, football, and family. Through their example, his mother, a physical therapist, and his father, a Lutheran pastor father, instilled in Andrew a strong desire to make a positive impact on the world.
In college, Andrew initially saw medicine as his path to making a difference, and worked in a pre-clinical neuroscience lab as well as a psychology lab for adolescents with anxiety and depression. But when Andrew took a class on the business of healthcare, he saw the potential to scale his impact through business rather than in clinical work.
Andrew was drawn to Kymera Therapeutics because of their innovative approach to targeted protein degradation, which was a relatively new concept in drug discovery back when Bessemer co-led their Series B in 2018. Despite there being skepticism in the field, Andrew was impressed by Kymera’s team and roadmap for overcoming early challenges in developing these complex molecules. After going public in 2020, Kymera’s success has continued to exceed Andrew’s expectations, with multiple drugs now in clinical trials showing promising data on their safety and efficacy in treating diseases.
Andrew sees himself as a passionate healthcare advocate, a strategic thought partner, and a champion for the teams he works with. He brings a personal approach to his role as an investor, always striving to understand the whole person behind the entrepreneur — their challenges, motivations, and aspirations in their professional lives and beyond. Really getting to know founders allows Andrew to be a more effective and empathetic listener and advisor. By helping his teams work through challenges with open-mindedness and honesty, Andrew can support entrepreneurs in reaching their full potential.
After moving to New England, Andrew discovered a love for skiing and it became a way to embrace the harsh winters rather than dread them. Now, skiing has become a cherished activity for Andrew and his family. Almost every winter weekend, he hits the slopes with his two young kids who are learning how to ski.
Collective Medical empowers care teams to improve patient outcomes by closing the communication gaps that undermine patient care. Collective Medical was acquired by PointClickCare Technologies in December 2020.
CopilotIQ of at-home medical care for people with high blood pressure, diabetes, and heart disease which uses monitoring technology, personalized care, and one-on-one weekly nurse calls.
Ginger is an on-demand mental health company that brings together behavioral health coaches, therapists, and psychiatrists, who work as a team to deliver personalized care, right through your smartphone.
Ginger merged with Headspace in October 2021.
Mural Health is a firm that develops technology for clinical trials and is committed to making it simple for people to take part in studies.
Peptone is an artificial intelligence and advanced atomic imaging techniques company that pursues a tricky class of potential targets for new medicines.
Plenful partners with healthcare organizations to increase revenue, decrease costs, and optimize workflows through their no-code automation and AI-enabled platform.
Qventus optimizes decisions in hospitals in real time to reduce costs, improve quality and experience.
Rimsys is the leading regulatory information management software for medtech.
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Subtle Medical uses AI to redefine the standards for medical imaging, making it faster, safer, and smarter.
Watershed is a verticalized Bio-IT cloud data lab technology that finds bioinformatics tools for biologists, helping biologists and bioinformaticians with assistance for more efficient and effective experimentation.
